Regeneration Technologies introduces advancements at AAOS

WHEN: February 5-7, 2003, at American Academy of Orthopaedic Surgeons (AAOS) meeting

WHERE: Morial Convention Center (New Orleans, LA)

WHY: Meet the only company with technology that sterilizes tissue with a process that is scientifically and clinically proven to eliminate donor to recipient disease transmission risk while preserving tissue strength and biocompatibility.

WHAT: Regeneration Technologies events at the meeting include:

• Presentation of two scientific papers involving biomechanical properties of allograft tissue after sterilization.
• Introduction of an exciting new BioCleanse safety advantage that will significantly impact the surgeon's practice.
• Presentation of distinguished speakers at its booth (#3731), including BioCleanse inventor C. Randal Mills, Ph.D., and other prominent tissue safety experts and surgeons.

HOW: For a one-on-one meeting with executive management or a member of the scientific team please call Ashley Tapp at Noonan Russo Presence at 212 845 4247. For any further information, or for press criteria to attend the event, please contact: Wendy Crites, Regeneration Technologies at 386-418-8888 or email: [email protected].

About Regeneration Technologies:
RTI processes allograft tissue into shaped implants for use in orthopedic and other surgeries. By processing allograft tissue into forms that can be used in many types of surgical procedures (orthopedic, urologic, craniofacial and cardiovascular surgery), RTI enables patients to benefit from the gift of donated tissues. Allografts processed by RTI include the patented MD-SeriesTM threaded bone dowels, Cornerstone-SRTM blocks, Opteform� and OptefilTM allograft pastes, Osteofil/RegenafilTM injectable bone paste, FasLataTM fascia lata tissue, and cortical bone pins and interference screws. BioCleanse is RTI's proprietary system for safely processing tissue while killing or inactivating all classes of conventional pathogens, viruses, microbes, bacteria and fungi.